New CAR T cells offer controlled treatment for solid tumors

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells-;a type of cancer immunotherapy-;that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.

Novartis and PeptiDream expand peptide discovery deal

Novartis and PeptiDream will develop peptide-based radioligand therapies and diagnostics under the latest deal. Credit: Taljat David / Shutterstock.com. Novartis and Japanese biopharmaceutical company PeptiDream

May 1, 2024

TAVR’s Win in Women; Chest Pressure During Cardioversion; Doc Goes to Space

The RHEIA trial, which found transcatheter aortic valve replacement (TAVR) superior to surgery for women, was among the highlights of the European Society of Cardiology

September 4, 2024

Artificial intelligence is a promising tool to disseminate nutrition-related information, study finds

The accuracy and reliability of nutrition information provided by two versions of ChatGPT.

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.